Akeso Inc

Common Name
Akeso
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
3,035
Ticker
9926
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Akeso Inc. is a biopharmaceutical company focused on the research, development, and commercialization of innovative, therapeutic solutions for the treatment of various diseases, particularly relating ...

Akeso's GHG Emissions Data Preview

In 2024, Akeso completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Akeso has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
c
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
c
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
c
0000000
Download Data

Verified Sources Behind Akeso’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Akeso’s data sources below and access millions more through our Disclosure Search.

a. Akeso's ESG Report 2024
a. Akeso's ESG Report 2024
b. Akeso's ESG Report 2023
b. Akeso's ESG Report 2023
c. Akeso's ESG Report 2022
c. Akeso's ESG Report 2022

Insights into Akeso's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Akeso amounted to 52,428.27 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Akeso increased by 85.72%, suggesting that the company faced challenges in reducing its emissions from its core operations. a b

Akeso's Scope 1 Emissions Over Time

20222023202402 k4 k6 k8 ktCO2e+1604%+359%
  • Total Scope 1
  • Year-over-Year Change

What are Akeso's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Akeso were 6,408.46 metric tons of CO₂ equivalent (tCO₂e). a

Has Akeso reduced its Scope 1 emissions over time?

Since 2022, Akeso's Scope 1 emissions have increased by 7,715.2%, reflecting a rising long-term trend in Scope 1 emissions over time. a c

Compared to the previous year (2023), Akeso's Scope 1 emissions increased by 358.54%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a b

What are Akeso's Scope 2 emissions?

In 2024, Akeso reported Scope 2 greenhouse gas (GHG) emissions of 46,019.81 tCO₂e using the location-based method. a

What methodology does Akeso use for Scope 2 reporting?

In 2024, Akeso reported its Scope 2 emissions using the location-based method. a

Akeso's Scope 2 Emissions Over Time

202220232024015 k30 k45 k60 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Akeso’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Akeso reported Scope 1 greenhouse gas (GHG) emissions of 6,408.46 tCO₂e and total revenues of USD 318 millions. This translates into an emissions intensity of 20.17 tCO₂e per millions USD. a

Akeso's Scope 1 Emissions Intensity Compared to Peers

0.5102005,000100,000Scope 1 Emissions (tCO2e)2202002,00020,000Revenues (Millions of USD)AASInnoCare PharmaYear: 2023Scope 1: 20 tCO2eRevenue: $M 104Scope 1 Intensity: 0.19 tCO2e/$MAntengeneYear: 2023Scope 1: 45 tCO2eRevenue: $M 10Scope 1 Intensity: 4.37 tCO2e/$MShanghai Henlius BiotechYear: 2023Scope 1: 6,909 tCO2eRevenue: $M 830Scope 1 Intensity: 8.32 tCO2e/$MRemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$MGenscript BiotechYear: 2024Scope 1: 39,377 tCO2eRevenue: $M 4,637Scope 1 Intensity: 8.49 tCO2e/$MAAAscentage PharmaYear: 2023Scope 1: 2,081 tCO2eRevenue: $M 34Scope 1 Intensity: 61.05 tCO2e/$MShanghai Junshi BiosciencesYear: 2024Scope 1: 5,308 tCO2eRevenue: $M 267Scope 1 Intensity: 19.88 tCO2e/$MEverest MedicinesYear: 2023Scope 1: 0 tCO2eRevenue: $M 19Scope 1 Intensity: 0.02 tCO2e/$MInnovent BiologicsYear: 2023Scope 1: 65 tCO2eRevenue: $M 953Scope 1 Intensity: 0.07 tCO2e/$MAAAurisco PharmaceuticalYear: 2024Scope 1: 2,731 tCO2eRevenue: $M 202Scope 1 Intensity: 13.51 tCO2e/$MCARsgen Therapeutics HoldingsYear: 2021Scope 1: 117 tCO2eRevenue: $M 4Scope 1 Intensity: 28.91 tCO2e/$MZai LabYear: 2023Scope 1: 15 tCO2eRevenue: $M 267Scope 1 Intensity: 0.06 tCO2e/$MSSSichuan Kelun-Biotech BiopharmaceuticalYear: 2023Scope 1: 6,335 tCO2eRevenue: $M 237Scope 1 Intensity: 26.78 tCO2e/$MZhifeiYear: 2023Scope 1: 14,211 tCO2eRevenue: $M 7,446Scope 1 Intensity: 1.91 tCO2e/$MKintor PharmaceuticalYear: 2021Scope 1: 29 tCO2eRevenue: $M 5Scope 1 Intensity: 5.35 tCO2e/$MAscletis PharmaYear: 2023Scope 1: 422 tCO2eRevenue: $M 9Scope 1 Intensity: 48.50 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,364Scope 1 Intensity: 9.75 tCO2e/$MVIVA Biotech HoldingsYear: 2022Scope 1: 1,404 tCO2eRevenue: $M 373Scope 1 Intensity: 3.76 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$MJacobio Pharmaceuticals GroupYear: 2023Scope 1: 34 tCO2eRevenue: $M 10Scope 1 Intensity: 3.48 tCO2e/$MAsymchem Laboratories (Tianjin)Year: 2023Scope 1: 46,854 tCO2eRevenue: $M 1,101Scope 1 Intensity: 42.55 tCO2e/$MWuXi Biologics (Cayman)Year: 2023Scope 1: 32,687 tCO2eRevenue: $M 2,603Scope 1 Intensity: 12.56 tCO2e/$MAlphamab OncologyYear: 2023Scope 1: 3,970 tCO2eRevenue: $M 34Scope 1 Intensity: 117.90 tCO2e/$MAkesoYear: 2024Scope 1: 6,408 tCO2eRevenue: $M 318Scope 1 Intensity: 20.17 tCO2e/$M

How does Akeso's GHG emissions intensity compare to its peers?

In 2024, Akeso reported a Scope 1 emissions intensity of 20.17 tCO₂e per millions USD. Compared to the peer group median of 8.49 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does Akeso rank on GHG emissions intensity within its industry?

In 2024, Akeso ranked 17 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Akeso is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Akeso's GHG Emissions Dataset?
Sign Up